in plasma and urine was estimated. The metabolites of H3-catecholamine were estimated at the same time in the urine.
The estimation of H3-catecholamine and its metabolites of each sample was carried out by the methods previously reported.5)- 7) Experiments in animals: Six rabbits were used, including 3 non-treated as control and 3 pre-treated with nitroglycerin administered sublingually 3min. before the experiment.
H3-catecholamine was infused intravenously, and 3min. after the infusion, the rabbits were killed with a blow. The radioactivity of H3-catecholamine and its metabolites in plasma and myocardium was estimated by similar methods as described before. Table I Clinical experiment: In all of the 5 cases with previous anginal attacks, the infusion of H3-epinephrine provoked a similar attack. On the otherhand, in cases without previous attack, the infusion of the same amount of H3-epinephrine did not provoke any attack. Furthermore, H3-norepinephrine did not provoke attack in both groups (Table I) .
RESULTS
The responses of blood pressure and heart rate to H3-epinephrine and norepinephrine, and the radioactivity of the H3-catecholamine in plasma in normal control without the treatment of any drug, during and after the infusion of H3-catecholamine are shown in Fig. 1 as typical cases. In these cases, the plasma level of H3-epinephrine or H3-norepinephrine became higher gradually during the infusion, followed by a rapid fall of the the radioactivity in plasma in the first 60min. after the end of the infusion and then followed by a slower decrease of this level. The radioactivity in plasma still remained 6 hours later from the end of the infusion.
Fig . 2 shows the results of 2 of the patients who were administered nitroglycerin sublingually during the infusion of H3-epinephrine or H3-norepinephrine. In 6 cases, nitroglycerin caused a remarkable fall of the plasma level of H3-epinephrine or H3-norepinephrine mostly within 3 to 5 min. after the administration of this drug and even during infusion. The results of the plasma level of H3-catecholamine in all cases of the nitroglycerin group are summarized in Fig. 3 (on the right) . On the contrary, the plasma H3-catecholamine of the non-treated group increased gradually as the infusion continued. Therefore, the level of H3-catecholamine in plasma was maximum just before the end of the infusion.
A urine analysis was carried out to determine the fate of these infused H3-catecholamine just after the administration of nitroglycerin. In the urine, Jap. Heart J. September, 1966 the radioactivity of H3-catecholamine was less in patients with nitroglycerin than in patients without any drugs (Fig. 4) . However, the excretion of these H3-acidic metabolites seemed to be increased in the nitroglycerin group as compared to the control group (Fig. 4) . Further investigation is necessary concerning the urine analyses. Animal experiments: H3-catecholamine in the plasma and myocardium was lower in the nitroglycerin group than in the non-pretreated rabbits (Fig.  5) . However, no particular changes were revealed in the radioactivity of H3-metanephrine or H3-acidic metabolites. 
